You are here: Formula Supply Related Updates

GMDI recognizes that the infant and metabolic formula supply issues is important to members and to the families we work with. Below are links to relevant information. We are working to keep this as up-to-date as possible.

June 23, 2022

Coram Access Discontinuation for Selected Metabolic Formulas 

June 16, 2022

Update from Abbott


May 26, 2022

Updated Press Release from FDA


May 24, 2022

Today, the U.S. Food and Drug Administration provided an update on steps it has taken that will lead to millions of cans of additional infant and specialty formula being available to U.S. consumers. Links to the press release and webpage are below.

Press release:

FDA Flexibilities to Yield Millions of Cans of Additional Infant Formula in Coming Months to Increase Supply Available to U.S. Consumers | FDA []


Enforcement Discretion to Manufacturers to Increase Infant Formula Supplies | FDA []


Time Sensitive:  May 17th FDA Stakeholders Call

May 16, 2022 - FDA provides new update - Statement on metabolic formula supply issues – A coalition of family support groups and other foundations has posted a statement and relevant links to their website, including statements from manufacturers of metabolic formulas about product supply.

May 13, 2022 - Statement from Abbott

May 11, 2022 - FDA Takes Important Steps to Improve Supply of Infant and Specialty Formula Products

FDA Investigation of Cronobacter Infections:  Powdered Infant Formula (February 2022)


If you have information to add, please contact us at

Contact Us

For more information about GMDI  or MetabolicPro
please contact us:


P.O. Box 1462
Hillsborough, NC 27278




Copyright 2022 by Genetic Metabolic Dietitians International